Showing results (241-250 of 291) with videos related to

Sort By:
Pageof 30
Alimentary Pharmacology & Therapeutics|September 10, 2024
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetesXianhua Mao, Ka-Shing Cheung, Jing-Tong Tan, et al.
Gut|April 3, 2024
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort studyXianhua Mao, Ka Shing Cheung, Jing-Tong Tan, et al.
Annals of the Academy of Medicine, Singapore|May 18, 2010
Severe infection with H1N1 requiring intensive care--lessons for preparedness programmesJaime M F Chien, Ban Hock Tan, Kok Soong Yang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2022
[Clinical Safety of NK Cell in the Prevention of Leukemia Relapse Post-transplantation and in Treatment of the Elderly Leukemia Patients]Jing Liu, Xiao-Li Zheng, Mei Xue, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trialKa Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui, et al.
Journal of Proteome Research|October 13, 2012
Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cellsKim Y C Fung, Cheng Cheng Ooi, Tanya Lewanowitsch, et al.
Antimicrobial Agents and Chemotherapy|November 1, 2016
Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection ModelYiying Cai, Tze-Peng Lim, Jocelyn Qi-Min Teo, et al.
Emerging Microbes & Infections|August 13, 2021
Genomic characterization of carbapenem-non-susceptible <i>Pseudomonas aeruginosa</i> in SingaporeJocelyn Qi-Min Teo, Cheng Yee Tang, Jie Chong Lim, et al.
Nature Communications|August 30, 2019
Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasmSho Kubota, Kenji Tokunaga, Tomohiro Umezu, et al.
Nature Communications|April 12, 2019
Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasmSho Kubota, Kenji Tokunaga, Tomohiro Umezu, et al.
Pageof 30